Skip to main content
. 2017 Mar 13;8(17):28641–28649. doi: 10.18632/oncotarget.16162

Table 5. Diagnostic thresholds of noninvasive models for liver fibrosis and cirrhosis.

Cut-offs Youden Index Sensitivity (%) Specificity (%) PPV (%) NPV (%) PLR NLR
GPR
 ≥ F2 0.49 0.63 83 80 65 91 4.15 0.21
 ≥ F3 0.62 0.65 90 75 39 98 3.57 0.13
 = F4 0.74 0.81 100 81 30 100 5.26 0
APRI
 ≥F2 0.41 0.39 80 59 47 87 1.96 0.33
 ≥ F3 0.44 0.36 80 56 25 94 1.81 0.36
 = F4 0.55 0.69 100 69 21 100 3.18 0
FIB-4
 ≥ F2 0.77 0.22 86 36 37 84 1.32 0.41
 ≥ F3 0.83 0.38 95 43 23 98 1.67 0.12
 = F4 0.91 0.49 100 49 14 100 1.95 0

GPR, gamma-glutamyl transpeptidase to platelet ratio index; APRI, aspartate transaminase to platelet ratio index; FIB-4, fibrosis index based on the 4 factors; PPV, positive predictive value; NPV, negative predictive value; PLR, positive likelihood ratio; NLR, negative likelihood ratio. The GPR cut-offs obtained in HBV mono-infection patients in West Africa by Lemoine et al. were 0.32 for ≥ F2, 0.32 for ≥ F3, and 0.56 for = F4, respectively.